Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Characterization of patients with steatotic liver disease (SLD)
The German SLD-Registry (Deutsches SLD-Register) a project of the German Liver Foundation (Deutsche Leberstiftung), managed by Leberstiftungs-GmbH Deutschland.
The German NAFLD-Registry is financially supported by: Advanz Pharma Specialty Medicine Deutschland GmbH und Gilead Sciences GmbH (Grant to German Livber Foundation) sowie Novo Nordisk Pharma GmbH (directly via Leberstiftungs-GmbH).
The following data can be documented:
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| SLD patients | No intervention |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Progression of liver fibrosis | Fibrosis stage is measured by elastography (elastometry kPa value). | through study completion, an average of 1 year |
| Activity of metabolic dysfunction-associated steatohepatitis (MASH) | Activity is measured via histology (NAFLD activity score represents the sum of scores for steatosis, lobular inflammation, and ballooning, and ranges from 0-8.) | through study completion, an average of 1 year |
| Cardiovascular events | The onset of the clinical outcome cardiovascular events (yes/no) | through study completion, an average of 1 year |
| Tumor diseases | The onset of the clinical outcome tumor diseases (yes/no) | through study completion, an average of 1 year |
Not provided
Not provided
Inclusion Criteria:
diagnosed SLD based on the following criteria:
credible assessment of alcohol consumption
written informed consent
Exclusion Criteria:
Not provided
Not provided
Not provided
The number of patients to be enrolled with SLD is limited to 10,000.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Stefan Zeuzem, Prof. Dr. | Johann Wolfgang Goethe University Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Infektiologisches Zentrum Steglitz | Berlin | Germany | ||||
| Leber- und Studienzentrum Checkpoint |
Not provided
| Label | URL |
|---|---|
| Related information on the registry | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Berlin |
| Germany |
| MVZ für Gastroenterologie am Bayerischen Platz | Berlin | Germany |
| Praxis für Innere Medizin mit Schwerpunkt Gastroenterologie Dr. med. Jeannette Schwenzer | Berlin | Germany |
| MVZ Viszeralmedizin GmbH | Cologne | Germany |
| Praxis Ludwig und Dikopoulos | Dornstadt | Germany |
| Fachinternistische Schwerpunktpraxis | Hamburg | Germany |
| Gastroenterologische Studiengesellschaft Herne | Herne | Germany |
| Leberstudienzentrum Kiel | Kiel | Germany |
| Eugastro GmbH | Leipzig | Germany |
| MVZ Dres. Eisenbach,Simon, Schwarz GbR | Leverkusen | Germany |
| Praxis Dr. med. Kerstin Stein | Magdeburg | Germany |
| CIM GmbH | Münster | Germany |
| St. Josefs-Hospital Medizinische Klinik II | Wiesbaden | Germany |